Bausch + Lomb Corporation — Balance Sheet (NYSE:BLCO) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Total assets 11.14 B13.44 B13.47 B14.02 B Total liabilities 4.04 B6.52 B6.92 B7.5 B Total equity 7.1 B6.92 B6.54 B6.52 B Total liabilities & shareholders' equities 11.14 B13.44 B13.47 B14.02 B Total debt 2.44 B4.56 B4.78 B5.05 B Net debt 2.17 B4.32 B4.59 B4.8 B

뉴스

Bausch + Lomb Corporation (BLCO) Discusses Glaucoma Pipeline Focus With Updates on BL1107 and Elios Transcript

Bausch + Lomb Corporation (BLCO) Discusses Glaucoma Pipeline Focus With Updates on BL1107 and Elios - Slideshow (NYSE:BLCO) 2026-03-23

바슈롬, 경쟁사 이디 치료제 지연에 RBC ’아웃퍼폼’ 유지

RBC reiterates Bausch & Lomb stock rating on DED rival delay

Tracking Carl Icahn's 13F Report - Q4 2025 Update (NASDAQ:IEP)

Teladoc (TDOC) Surges 5.1%: Is This an Indication of Further Gains?

Toymaker Hasbro joins wave of companies suing U.S. government over IEEPA tariff payments

Bausch + Lomb stock hits 52-week high at $18.86

L’Oreal, Dyson, Bausch + Lomb become the latest to sue for Trump tariff refunds

H.C. 웨인라이트, 바슈롬 목표 주가 20달러로 상향

H.C. Wainwright raises Bausch & Lomb stock price target to $20

Bausch + Lomb Q4 Earnings Review: Still A Buy, With Some Caveats (NYSE:BLCO)